74 related articles for article (PubMed ID: 1656139)
21. Epstein-Barr virus infection and associated products (LMP, EBNA2, vIL-10) in nodal non-Hodgkin's lymphoma of human immunodeficiency virus-negative Japanese.
Ohshima K; Suzumiya J; Tasiro K; Mukai Y; Tanaka T; Kato A; Kikuchi M
Am J Hematol; 1996 May; 52(1):21-8. PubMed ID: 8638607
[TBL] [Abstract][Full Text] [Related]
22. Lymphoproliferative disease in mice infected with murine gammaherpesvirus 68.
Sunil-Chandra NP; Arno J; Fazakerley J; Nash AA
Am J Pathol; 1994 Oct; 145(4):818-26. PubMed ID: 7943173
[TBL] [Abstract][Full Text] [Related]
23. T cells or active Epstein-Barr virus infection in the development of lymphoproliferative disease in human B cell-injected severe combined immunodeficient mice.
Coles RE; Boyle TJ; DiMaio JM; Berend KR; Via DF; Lyerly HK
Ann Surg Oncol; 1994 Sep; 1(5):405-10. PubMed ID: 7531601
[TBL] [Abstract][Full Text] [Related]
24. SCID/human mouse model of central nervous system lymphoproliferative disease.
Bashir R; Okano M; Kleveland K; Pirrucello S; Masih A; Sanger W; Fordyce-Boyer R; Purtilo D
Lab Invest; 1991 Dec; 65(6):702-9. PubMed ID: 1684402
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of HHV-8/KSHV infected primary effusion lymphomas in NOD/SCID mice by azidothymidine and interferon-alpha.
Wu W; Rochford R; Toomey L; Harrington W; Feuer G
Leuk Res; 2005 May; 29(5):545-55. PubMed ID: 15755507
[TBL] [Abstract][Full Text] [Related]
26. Neutrophils contribute to the biological antitumor activity of rituximab in a non-Hodgkin's lymphoma severe combined immunodeficiency mouse model.
Hernandez-Ilizaliturri FJ; Jupudy V; Ostberg J; Oflazoglu E; Huberman A; Repasky E; Czuczman MS
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5866-73. PubMed ID: 14676108
[TBL] [Abstract][Full Text] [Related]
27. B cells and herpesviruses: a model of lymphoproliferation.
Barozzi P; Potenza L; Riva G; Vallerini D; Quadrelli C; Bosco R; Forghieri F; Torelli G; Luppi M
Autoimmun Rev; 2007 Dec; 7(2):132-6. PubMed ID: 18035323
[TBL] [Abstract][Full Text] [Related]
28. Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder.
Roychowdhury S; Baiocchi RA; Vourganti S; Bhatt D; Blaser BW; Freud AG; Chou J; Chen CS; Xiao JJ; Parthun M; Chan KK; Eisenbeis CF; Ferketich AK; Grever MR; Chen CS; Caligiuri MA
J Natl Cancer Inst; 2004 Oct; 96(19):1447-57. PubMed ID: 15467034
[TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr virus negative clonal plasma cell proliferations and lymphomas in peripheral T-cell lymphomas: a phenomenon with distinctive clinicopathologic features.
Balagué O; Martínez A; Colomo L; Roselló E; Garcia A; Martínez-Bernal M; Palacín A; Fu K; Weisenburger D; Colomer D; Burke JS; Warnke RA; Campo E
Am J Surg Pathol; 2007 Sep; 31(9):1310-22. PubMed ID: 17721185
[TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr virus-associated B-cell lymphoproliferative disorders in angloimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified.
Zettl A; Lee SS; Rüdiger T; Starostik P; Marino M; Kirchner T; Ott M; Müller-Hermelink HK; Ott G
Am J Clin Pathol; 2002 Mar; 117(3):368-79. PubMed ID: 11888076
[TBL] [Abstract][Full Text] [Related]
31. Characterization of Epstein-Barr virus-induced lymphoproliferation derived from human peripheral blood mononuclear cells transferred to severe combined immunodeficient mice.
Okano M; Taguchi Y; Nakamine H; Pirruccello SJ; Davis JR; Beisel KW; Kleveland KL; Sanger WG; Fordyce RR; Purtilo DT
Am J Pathol; 1990 Sep; 137(3):517-22. PubMed ID: 1975985
[TBL] [Abstract][Full Text] [Related]
32. Homing and antigenic characterization of a human non-Hodgkin's lymphoma B cell line in severe combined immunodeficient (SCID) mice.
de Kroon JF; Kluin PM; Kluin-Nelemans HC; Willemze R; Falkenburg JH
Leukemia; 1994 Aug; 8(8):1385-91. PubMed ID: 8057678
[TBL] [Abstract][Full Text] [Related]
33. Imaging findings in immunosuppressed patients with Epstein Barr virus-related B cell malignant lymphoma.
Sauter A; Faul C; Bitzer M; Bares R; Kraus S; Fenchel M; Horger M
AJR Am J Roentgenol; 2010 Feb; 194(2):W141-9. PubMed ID: 20093565
[TBL] [Abstract][Full Text] [Related]
34. Characterization of clonality of Epstein-Barr virus-induced human B lymphoproliferative disease in mice with severe combined immunodeficiency.
Nakamine H; Masih AS; Okano M; Taguchi Y; Pirruccello SJ; Davis JR; Mahloch ML; Beisel KW; Kleveland K; Sanger WG
Am J Pathol; 1993 Jan; 142(1):139-47. PubMed ID: 8380952
[TBL] [Abstract][Full Text] [Related]
35. Senile EBV+ B-cell lymphoproliferative disorders: a clinicopathologic study of 22 patients.
Oyama T; Ichimura K; Suzuki R; Suzumiya J; Ohshima K; Yatabe Y; Yokoi T; Kojima M; Kamiya Y; Taji H; Kagami Y; Ogura M; Saito H; Morishima Y; Nakamura S
Am J Surg Pathol; 2003 Jan; 27(1):16-26. PubMed ID: 12502924
[TBL] [Abstract][Full Text] [Related]
36. Effects of cyclosporine on human B-cell lymphoma development in vivo.
Boyle TJ; Coles RE; Kizilbash AM; Lyerly HK
Surg Oncol; 1992 Feb; 1(1):79-86. PubMed ID: 1341239
[TBL] [Abstract][Full Text] [Related]
37. Lymphoma induction by human B cells in scid mice.
Amadori A; Veronese ML; Mazza MR; Zamarchi R; Mion M; D'Andrea E; Menin C; Del Mistro A; Leszl A; Calderazzo F
Leukemia; 1992; 6 Suppl 3():23S-25S. PubMed ID: 1318472
[TBL] [Abstract][Full Text] [Related]
38. Preliminary report: growth of Hodgkin's lymphoma derived cells in immune compromised mice.
Kapp U; Wolf J; von Kalle C; Tawadros S; Röttgen A; Engert A; Fonatsch C; Stein H; Diehl V
Ann Oncol; 1992 Sep; 3 Suppl 4():21-3. PubMed ID: 1450076
[TBL] [Abstract][Full Text] [Related]
39. The evolving therapeutic approaches for Epstein-Barr virus infection in immunocompetent and immunocompromised individuals.
Okano M
Curr Drug Targets Immune Endocr Metabol Disord; 2003 Jun; 3(2):137-42. PubMed ID: 12769785
[TBL] [Abstract][Full Text] [Related]
40. Lymphoproliferative disease in human peripheral blood mononuclear cell-injected SCID mice. I. T lymphocyte requirement for B cell tumor generation.
Veronese ML; Veronesi A; D'Andrea E; Del Mistro A; Indraccolo S; Mazza MR; Mion M; Zamarchi R; Menin C; Panozzo M
J Exp Med; 1992 Dec; 176(6):1763-7. PubMed ID: 1460431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
